Superior Resources Limited (ASX:SPQ)

Theseus Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0.4	0.95	3.95	4.1	1.72	1
Short-Term Investments	0.06	0.08	0.04	0.03	0.04	0.01
Cash & Short-Term Investments	0.46	1.02	3.99	4.13	1.76	1.02
Cash Growth	-78.44%	-74.35%	-3.44%	135.28%	72.90%	734.64%
Other Receivables	0.05	0	0	0.03	0.02	0.01
Receivables	0.05	0	0	0.03	0.02	0.01
Prepaid Expenses	-	0.02	0.1	0.05	0.03	0.03
Total Current Assets	0.51	1.04	4.09	4.21	1.8	1.05
Property, Plant & Equipment	16.32	15.16	11.78	8.9	6.08	4.47
Other Long-Term Assets	0.08	0.08	0.08	0.04	0.03	0.03
Total Assets	16.91	16.29	15.94	13.15	7.91	5.55
Accounts Payable	0.02	0.05	0.14	0.16	0.26	0.11
Accrued Expenses	0.43	0.42	0.45	0.48	0.39	0.36
Other Current Liabilities	0.02	0	0.01	0.03	0.01	0.06
Total Current Liabilities	0.47	0.48	0.6	0.66	0.67	0.53
Other Long-Term Liabilities	-	-	-	-	-	0.04
Total Liabilities	0.47	0.48	0.6	0.66	0.67	0.58
Common Stock	27.22	26.14	24.32	20.59	14.96	12.2
Retained Earnings	-7.93	-7.48	-6.07	-5.19	-4.59	-4.02
Comprehensive Income & Other	-2.85	-2.84	-2.91	-2.92	-3.12	-3.21
Shareholders' Equity	16.44	15.82	15.34	12.49	7.25	4.97
Total Liabilities & Equity	16.91	16.29	15.94	13.15	7.91	5.55
Net Cash (Debt)	0.46	1.02	3.99	4.13	1.76	1.02
Net Cash Growth	-78.44%	-74.35%	-3.44%	135.28%	72.90%	734.64%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	2,170	2,001	1,835	1,701	1,381	1,017
Total Common Shares Outstanding	2,170	2,001	1,835	1,701	1,381	1,017
Working Capital	0.04	0.57	3.48	3.55	1.14	0.52
Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.00
Tangible Book Value	16.44	15.82	15.34	12.49	7.25	4.97
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.00
Machinery	0.01	0.1	0.1	0.1	0.1	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.